Axis Kickoff Required Vaccination, Mass COVID-19 Infections

IT
IPVM Team
•Published Apr 20, 2022 12:28 PM

Axis Americas vaccine requirement has caused controversy and many employees to resign.

IPVM Image

Now, numerous attendees at Axis Kickoff contracted COVID-19 leading to a fresh round of debates about Axis policy, reflecting the challenges in broader American life over COVID policies.

Axis *******

**** ****, **** *** *** ****** Kickoff **-******, ******** ******** ******** ** people, ********* **** *** *** ********. Over *** **** * *****, **** of ***** ****** **** **** ********* or ******** *** ** *****-**.

COVID-19 **********

**** ********** **** *** ********* **** vaccinated *** **** * ****** ** people ****** ********, ** ** ***** IPVM ********:

IPVM Image

Axis ********

**** ********* ** **** ********* ** saying:

*** ****** ** ********* ******** ** the *********** ****** **** *** **** resolved.********* *** ********** **** ***** ********* our ***** ** ******, ** **** that ****** **** ********** **** ******* any ****** *******, *** ** **** them * ***** ********.

**** ******* ********* *** ******** ********* being ******** ****** "**** ********, ****** are ***** ********". ** ** *** know *** ***** ****** *** ********, though **** *** *** **** ****** were ********** ** *********** ** ***** individuals.

*** *******

** **** ******* **, ****** **** vaccinated ****** **** ******* *** ****** illness ** *** **** **** **** contracted *****-** ** ** ********* ** the **** ***** ** ********* ** the *******.

**** *******

*******, ** ** *** *********** ** public *******, *** **** **** **** required ********, **** ********** *** ********* who ******* ** ******, *** *** many ********* **** ***** ********, ****** criticism ** ***** **********.

************ ******

********** *** ** **** ** *** many **** ********* ******** **** **** or **** *** ******* **** ****** they ********** *** *** **** **, to **** ***** ***. **** **** infection ** **** ******* **** ******* fuel ** *** ****** ** ********** to ************.

****** ****** ***** ****** ****

*************, ***** *** ***** *********** ****** Axis ****** ******** ********, ****'* ****** problem ** ********** **** ******* *********(*** ****** ** ***** ****** *** a ********* ***** ****** ******** *** Axis) **** *** ******* ******** *** partners, ********* *** ********** **** ** look *********.

Comments (46)
UI
Undisclosed Integrator #1
•Apr 20, 2022

******* ** *** ** **** ****, as *'* **** ** **** ***** a ********** *** ********** ************.

(1)
(37)
UI
Undisclosed Integrator #1
•Apr 21, 2022
In reply to Undisclosed Integrator #1

IPVM Image

(6)
UI
Undisclosed Integrator #2
•Apr 20, 2022

*'* ** ******** ** **** **** of *****. ***** ******** ***** *** small *** ** **** **** * small ********** ** ********* **** **** reasons *** *** ******* *** **** and *** *********** **** ***** **** are ********** *** ***** *** ****. It ** * ******* ******* ******** for ** ****** *** **** ** keep *** ********* *** ********* **** and **** * ************* ***** ****'* best *** ******* ******** ** ****. Exploiting **** ****** ***** ** **** as **** ***'* ******* *** ******. It **** ***** **** **** *********. Hardly *** ***** *'* ******* *** from ** ************ ** ****.

(36)
(13)
(1)
(1)
U
Undisclosed #3
•Apr 20, 2022
In reply to Undisclosed Integrator #2

***% *****.

**'* *** **** ** **** ***** that ********** ****** *** ********, *** never *** * **** ******** ** to ***** * *****.

(10)
(1)
UM
Undisclosed Manufacturer #5
•Apr 20, 2022
In reply to Undisclosed #3

* *** ***** ***** *** (***** mild ********, ***** ******), ****'* **** if * *** ** ** ******** I *****'** **** ** ** ** IPVM *******.

(1)
(12)
U
Undisclosed #9
•Apr 20, 2022
In reply to Undisclosed #3

**'* *** **** ** **** ***** that ********** ****** *** ********, *** never *** * **** ******** ** to ***** * *****.

*** *** **** *** *****, ***-******* have ****** **** ******** ******* *** spread. ****'** ********** ***** ***** **** now.

(19)
(8)
(8)
(1)
U
Undisclosed #9
•Apr 22, 2022
In reply to Undisclosed #9

***. *********.

********* *** ***, ***, ***, *****, and ******* ** *** ****** ** vaccine ************* **** ****** **** *** it ***** **** *** **** *****, as **** ** ******* **** ******* of ******** *** *** ************** ****** is ***** ***** *********.

(11)
(3)
(1)
(5)
(2)
Avatar
Ted Havill
•Apr 25, 2022
In reply to Undisclosed #9

*'** ****** *** *** ***** ****** had * *** ****.

* **** ****** *** ***** ***** of *****. * ***'* **** **** on ******.

****.... ***** ** ** ** **** anti-mask/anti-vaxxer.

****: $*!* *******.

(1)
UI
Undisclosed Integrator #22
•Apr 26, 2022
In reply to Undisclosed #9

******** ******* ****'** ******** ***** **** you *** **** ******** ******** ******, basic ******** *******, *** *** ********* and ************ *********** ** ***** ******** medical *******, *** *** ***** ******* time ******* ****?

(2)
(1)
U
Undisclosed #9
•Apr 26, 2022
In reply to Undisclosed Integrator #22

******, **** ** *** "********" *** of *** ******** ********* **** **** credible *** ********.

*** ***: *** ***'*.

(1)
U
Undisclosed #9
•Apr 20, 2022
In reply to Undisclosed Integrator #2

*** **** ********* ***** ** *** story ** ** *** **** *********... "****** ****** ***** ****** ****"

(4)
(1)
U
Undisclosed #10
•Apr 20, 2022
In reply to Undisclosed Integrator #2

* ***** *** **** *** *** all ** *** ****** **** **** coerced **** ******* ** *** *** regret ** ** *** **** **** refuse ** *** *******.

***** *** **** *** *** ****** that **** ***** *** **** **.

* ***** *** **** *** *** anyone **** *** *** ******* ********* to *** *******. ** *** ***, you *** **** ********* ** ** some ***** ****** *****.

* ***** *** *** ** ***** of ******* ***** **, *** **** it ***** ** ****. *** *** reality **, *************** ****** ****** ******* ** **, people********* ***** **** **** ** ***** today, *** ** ********* ***** ***** **********. ******* **** people **** ** ** ***** ** the **** *** ******* ******* ******* and ******** *******.

**** ** ******, ** ****** ** many ******* ****** **** ********* ******** and **** ****** ****** ** ** the ****. *********, *** **** *** watch ***** ******** ***** **** ***** the **** ****.

** *** ***'* ****, ****** ** past *** ****. ** *** ******** with *** ***********, **** *** **** and ******* **** ********. ** ***** spend **** **** ******* ********* **** opposes **** ******** *** ***** ********** rather **** ***********. **** ** * good ***** ** *****.***** ******** • ********'* ****** *******

...*** **** ** **** ***** *** of *** ********** ********* **** **** year **** *** ***** ********** *****. Mask? ******* ********?

**** * ***** ***!

(25)
(9)
(1)
(14)
(1)
UI
Undisclosed Integrator #2
•Apr 20, 2022
In reply to Undisclosed #10

*'** **** ********** ***********. ***** ***!

Children's ****** ******* is an American ***(*)(*)***************** ***** ****** ***** *******-***************** *** *** **** ********** ** one ** *** **** ******* ** misinformation ** ********. ******* ***** *** name ***** ******* ******* ** ****, it ** ******* ******** *. ******* **.[*][*]*** ***** *** **** *********** ******* various ****** ****** ********, **** ** vaccination *************** ** ******** *****.[*]*** ***** *** **** ************ ********* *********** *** ****** ******, *********** ******** and *********** ** ******* ****-******* *********** and ***********.[**][**][**]********* ******* *********** *** ************ ** overwhelming********** ************** *** ****** *** ************* ** vaccines.[**][**][**][**]

(6)
(6)
(14)
U
Undisclosed #10
•Apr 20, 2022
In reply to Undisclosed Integrator #2

****, **************** **** ** "**************"? *** *** is *********? * ****, *** ***** that?

**** **** ******* *** *******. ***** at *:** (** ***** *** ***** thing). **** ******* **** ** **** is ***** *****.

******: *** **** ******** ***** *** get **********. ** ** *** ****** if *** *** ********.

*** **** **** **, **** ** "misinformation"? ****** *** * ******.

**** * ******* ***.

(7)
(3)
(1)
(6)
(1)
UE
Undisclosed End User #14
•Apr 21, 2022
In reply to Undisclosed #10

"**************" ***** ** ******** *** ********** in *********, ********-***** *******

(5)
(1)
(2)
(1)
(3)
U
Undisclosed #9
•Apr 22, 2022
In reply to Undisclosed End User #14

"**************" ** **** ******* **** ******** have ******* **** *******. **** **** the ***** "******", "****", "*********", "********", etc.

***** **** ** ***** ******** *** everything *** ******* **** *** ********** meaning ** **** *****.

(6)
(3)
(5)
UI
Undisclosed Integrator #22
•Apr 26, 2022
In reply to Undisclosed #9

***** **** ** ***** ******** *** everything *** ******* **** *** ********** meaning ** **** *****.

** * ************, * ***** *****.

"**************" ** **** ******* **** ******** have ******* **** *******.

** * ************, * ********** ******** and ** ****** *** **** ***** conservatives **** *** **** ******* ******** like ****. *** ****** ** ***** enough ** ******** ******* **** ***** which ** **** ******** **** ******* doing.

(4)
(2)
(1)
U
Undisclosed #10
•Apr 22, 2022
In reply to Undisclosed End User #14

"**************" ***** ** ******** *** ********** in *********, ********-***** *******

* **** **** *** ********.

***'* ** **** *** **** ** the ********.

***** ******** • **** ** ** 48 • ********'* ****** *******

* *** **** ******** **** **** discussing ****** **** ***** *****, ***********, and ***** **** *******. ******* ******* as ************** (***** *****). *** *** even *** ** ******* ********** ** and ****** ** **** **.

*********, *** *** ***** **** ******* say ****** ** **** *** *** true, **** ***** ****** **. ******** the ***** **** *** ***** *** the **** **** ******* **? * remember ** **** **** *** **** and **** ***** *** *** **** and ***. *** *** ****? *** I ******** *** **** ********** ******* immunity. *** ** **** **** ****** they *** *****, ***, ** ************** label... **, "*** ******* *******".

******* ******* **** ***** **** "**************", I **** **** *** *** ***** truthful ** ******** ** ***** ********* (weather *********** ** *************).

(3)
(3)
(4)
UI
Undisclosed Integrator #19
•Apr 25, 2022
In reply to Undisclosed #10

** ****, "**************," ** *** *****-**** form ** "*** ******** ***** ********* with *** *********** ** *** ****** speaking."

****** ****, **** *******.

(4)
(1)
U
Undisclosed #9
•Apr 21, 2022
In reply to Undisclosed #10

******* ***** **** **** *** ***** into ***** ********** *****, *** ******* of **** ********* **, *** **** for *** ********** ** **-***** ***** unconstitutional ******** *** *** **** ** being ***** ** *** ********.

(9)
(2)
(1)
UM
Undisclosed Manufacturer #15
•Apr 21, 2022
In reply to Undisclosed #10

** ***** ***** **** **** ******* something **** ******* **** ******** *** think ********** ****** **** ***********

**** ********* ** ******* ** ****. What **** *** **** **** ******* your *** ******** *** **** ** the *****....***** **** ****** ** ****** emotional ** **.

U
Undisclosed #10
•Apr 22, 2022
In reply to Undisclosed Manufacturer #15

** ***** ***** **** **** ******* something **** ******* **** ******** *** think ********** ****** **** ***********

**** ********* ** ******* ** ****. What **** *** **** **** ******* your *** ******** *** **** ** the *****....***** **** ****** ** ****** emotional ** **.

*** **** ***** ********* ** ******* taking *** **** ** *** **** is *** * ****** ***** ** discuss.

(1)
UI
Undisclosed Integrator #18
•Apr 25, 2022
In reply to Undisclosed #10

"*** ****** **** ** * ********** individual ** *** ** **** **** in *** ***."

- ************

(1)
UI
Undisclosed Integrator #13
•Apr 20, 2022
In reply to Undisclosed Integrator #2

*'* ** **** *'* ******* **** quality ********* **** ** *** *** that *** *** **** ******* ** this **** ** ****** ****** * larger *******!

(11)
(3)
(5)
JH
John Honovich
•Apr 21, 2022
IPVM
In reply to Undisclosed Integrator #2

***'* ******* *** ******. ** **** feels **** **** *********

***** ************ *** ***** **** *** of ****** ********. *** *******, ** the **** ***:

*** **** ******* ****** *** *********: How ********** *** ********

* ** ********** *** ******* *** our ********** **** **** ******** *********** and **-**** *******, ** * ** not "****-***".

**** ****, * *** ********** *** many ********* *** *****, ********** ***** how ***** ************ *** ***** ******* and ********* ******** ******, ********* ** the ****** ** * ******.

*** ***** ****, *.*., ****** *** the ********* ** **:

(2)
(1)
(3)
(1)
UI
Undisclosed Integrator #2
•Apr 21, 2022
In reply to John Honovich

** * ********* ** ** ***** post ** **** *******, **** ***'* the **** *'* ******* *** ** IPVM. *** ********, ***/****-***, ***. *** treated ** ****** ** ***** **** outlet. ***** ** * ***** * go ** ***** **** ***** ** industry *** ** **** ** ******** our ********. *** *** ********* ******* what *** **** *** **** ***'* what * **** **** ***. ******* on **** (*** ***** ******** ******** to *** ********) ** *** * rise *** ** **** ******* *** put **** **** ** **** **** but **'* **** ** * ***** look. * ***** *** **** ** and ****'* *** *** ****** ** that *** ***** *** ******* ********** at *** ***. **** ** *** real ***** ***** **** ***** *** that ******* ** **.

**********, ****** **% ** **** ******* agree **** ** ******** ******.

(3)
(3)
(1)
JH
John Honovich
•Apr 21, 2022
IPVM
In reply to Undisclosed Integrator #2

******* ** **** (*** ***** ******** response ** *** ********) ** *** a **** *** ** **** ******* may *** **** **** ** **** site *** **'* **** ** * gross ****

* ** *** ****** ** *** a ****, **** *** *** ** an ********* ***** *** *** *** for **** ****** ** **. ** are * *********, *** * ******* consulting *******, *** ***** **** ** for ********.

**** *** ***** *** ******* ********** at *** ***. **** ** *** real ***** ***** **** ***** *** that ******* ** **.

*** **** *******'* *** ****:**** ********** *** ****** ********.

(2)
(1)
Avatar
Dwayne Cooney
•Apr 22, 2022
In reply to Undisclosed Integrator #2

**** ***'* *** **** *'* ******* for ** ****

***** *** **** ****** ** *** industry. *** ***** ******* **** ******** to ***** *********** **** ******** ***** IPVM ******** ********** *** ************* *******.

***** *** ***+ ***********. **'* ******** safe ** ****** **** *** ******** do *** ********* *** *** **** reasons *** ** * **.

**** ******* ** **** ** ** for **** *******. *** **** ***** or ****.

(4)
(1)
UI
Undisclosed Integrator #22
•Apr 26, 2022
In reply to Undisclosed Integrator #2

*** ** ******* *** ********** ***** "mass **********" **** *** ******* ****** says "* ****** ** ******". **** tabloid ********** **** ****.

****: * ******* ******* *******

(1)
(1)
UI
Undisclosed Integrator #4
•Apr 20, 2022

**** ** ****’ ******** ******* ** PR.

***** **** ** ***** ********* *** quitting **** ************, **** *** ******** because **** ***’* **** *** ******** inventory ** **** ** ***** ********* and ***’* **** * ***** *** on **** *** ********* **** **** in.

**** ** “*-**”…*********** **** ******* ************ elsewhere.

(5)
(1)
(7)
(7)
U
Undisclosed #10
•Apr 20, 2022
In reply to Undisclosed Integrator #4

**'* * ****** ******!

UE
Undisclosed End User #6
•Apr 20, 2022

****'* **** *** ****** ********? "********** New **********," ****... ********! ***** *** vaccine ************ *** *** *****, *** to **** **** *********' ******* ** inexcusable, ** *** **** * **** Michaels ******** **** ******** ********?

IPVM Image

(4)
(10)
UE
Undisclosed End User #7
•Apr 20, 2022
In reply to Undisclosed End User #6

*'* ****** **** **** *** ** make * ***** ****......

(1)
(6)
U
Undisclosed #8
•Apr 20, 2022

**** ***** *****, ***.

(1)
(5)
U
Undisclosed #9
•Apr 20, 2022
In reply to Undisclosed #8

**** ***** *****, ***.

***** ***%. *** ****-*** *****'* ***** so **** ***** ****.

(1)
(3)
U
Undisclosed #11
•Apr 20, 2022

****. *** ******* ***'* ******* *** spread ** *****?

(2)
(4)
UI
Undisclosed Integrator #12
•Apr 20, 2022
In reply to Undisclosed #11

** **** **** ******, ** **** protect ******** ****

(1)
(2)
UM
Undisclosed Manufacturer #16
•Apr 22, 2022

* ***** *** ****** ******** *** closer ** **, *** **** **** is ****** **** * ******** ******** “Axian”, **** *** *** ** **********.

(1)
(1)
UI
Undisclosed Integrator #17
•Apr 25, 2022

"* ***** ****. *** **** ******* move ** *** ** ****."

(2)
(1)
(1)
UI
Undisclosed Integrator #19
•Apr 25, 2022

**, ******* **** ** *** * fevah *** ***?

**'* ***** ******** ** ************** ** pro-vaccines-and-science-in-general, *** ****-*****-***-********-***********-**********-******-****-***-********-*******-********.

******; * **** **'* **** **** to ***** *** ***********, *** *******, real ****, *** **** ****** *** NUANCED.

*** **** **** *** *** ***, and ****** *'** *** *** *** ever ************ ********** * ****** ***** of *** * ****** **** ** life **** * **. ********* *** the ********** *********** ********* ******* *** shots ** *** "****** ******" *******.

****** * **** *** * ***** is, * **** *** **** *** advice. *** ******.

*** **** *'** ****** *** ***** of **** ******.

(4)
(1)
UI
Undisclosed Integrator #20
•Apr 26, 2022

* ******* ****** ***** ******* ********* to *** ******** **** ***** ******. Full ****.

(5)
(1)
U
Undisclosed #21
•Apr 26, 2022

* **** * ********* **** ** this, ** * ****** ********** ******** under ******** *************** **** *** ***** and *** * ******* **********/ ********** in *** ******** ***** ** ********* and ********** ***** ********, * **** at **** ******** ** ******* ****** humor ***.

* **** ***** *** ***, ******. I ***** ***** ** **** ** came *** ***** *** ****** ***, I **** ***** ** ***** ******* by *** ******** *******. ** ***** a **** **** ** *** ********* like * "****" ****** *** **** all *** **** ******* ***** *** long **** ******* ********* ***. ** to *** * **** **** *** rushed ** * **** ** ****** Pharma ***** *** **** ******** * blank ***** ** *** ********** ** they ***** ******* **** **** ***** for, **** *** **** ** **** fuzzy **** ******* **** ****** **** has ** **** ********* ** ****. How **** ***** ** ** **** from ******** ************ **** **** **** the **** *** ******** *** ***** are ** ****** ** *** **** the ***** *** ***** ******* ******* X **** *** ** ****** **** so **** *** **** ** ******* as ******** **** ** **** ** have * ******** ******* ** ***** working **** * ******* ** *** products **** ****** ***** ***** *** design *****. ** **** *** ****** a *** ***** ** ***** ** that *** *** ** **** **** about. ** **** *** *** ***** Spectra * *** ** ***** ***** 3 ***** *** ******* **** *** brittle *** ***** **** *** *** to ****** *** ****** ******. ** on *** ** **.

*** ********** ********** **** ******** *** division *** ** ******, **** ****** how ******** ***** *** **** ** the *** *******, **** ** *** ever ****** ******* ** ******** **** other **** *** **** ** **** a **** *** *** ***** **** that *** *** *** ** ** evil? *** **** ****** *** ****** are ***** ** *** ******* **** mutants ** **** *** **** ***** with *** *** ******** ********* ***** the **** ***** ****** ** ****-**** only ** **** ***** ** **** sides ** ***** *** *** **** the ********* **** ** ** ***** again ** **** *** ***** ** the ******* ********* *******.

**** * **** **** *********** ** that **** ****** **** **** *** impose ************ **** **** ** ****** to ** ******** ** *** **** of *** ***** *** **** ** the ************ ***** **** *****. ***** is ***** ****** ****-**** *** "*******" ,that **** ***** ******* **** * tangent *****, ***** ***** *** ********* materials *** *** ***** ****, ** leaving ***** ** ** ********* *** made **** ***** **** ** **** 1st ***** ********* ******. ********* *** businesses *** ********** ***** ********* ** assemble ** *********** **** ******* ******** over ** *********** ******* ******* ***** goods *** ******** ** **** ******* there *** *** ****** ****** *** want ** **** ***** *** ******* standards *** *** **** *** **** cut ** ********* *** ******** ******. (in ** *** **** * *** cook ** ********* ** * *** city *** ***** $*** **** **** what * ** *** ***** ******* labor ******** *** ****** **** ** jump ****** **** **% ** *** hoops * **** **, ** ******** my ***.

*** **** **** ** **** **** will *** **** ** **** ***, and ** * **** ** ***** right ** *** ****( ** ***** warlord) **** ********** *** **** * do *** *** ***** ** ***** to ******* *** ****** * **** in *** ******** *** ******** *** hopefully **** ***** ** **** **** to **** **.

** *** * **** **** ** here ***** *** **** **** ** the *** ** ***** ** ***** prime, *** *** *** *** ****** AXIS **** ***** ** **** *********** try ** *** *** **** **** with ******** ** *** ******** ******* to **** ** **. ****'* ********* was *** ***** **** ** *****'* then **** **** ***** ****** *** IP ****** **** ***...

(1)
(1)
UE
Undisclosed End User #7
•Apr 26, 2022
In reply to Undisclosed #21

***** ***, *** ******** ************* *** pharmaceutical ********* *** ********** ** ******-**-****** comparison.

** ****, *, **** **** ******, often ******* **** *** ***** *** and *** ****. * **** **** all **** *** **** *********** *** requirements **** *************, *******, *** ***** agencies **** ******** ********* ** *** better ** ***** * ***** **** comparing * ****** ** ** ********** drug.....

U
Undisclosed #11
•Apr 26, 2022
In reply to Undisclosed End User #7

*** ** ******* **** ******* ** saying **** **** ***** **** **** earlier ** **** ****** *** ****** funny.

*** **** ***** ** ** ***** off **** ** **. **** ***** post ** ********* (***** * **** no ****** *** ***, ***) - but * ***** *** **** ********** missed *** **** ** **'* ****** point.

***** **** ** ******* ******** ************* to ****** *********?

* ************ ***** **'* ******** ******** that * *****: *.*. * ***'* trust ****.

U
Undisclosed #9
•Apr 28, 2022

****, *** ******** ** **** ** the *.*.

/******

(1)
JH
John Honovich
•Jul 24, 2023
IPVM

******: **** ******** *** ***** *** COVID ******* *********** **** *** ******* telling **:

*** ****** *** ******* **** ******* requirements, ** *** ****** ********* ** Axis ***** ********* ********* ******** ***** of *********** (*.*., ************* ******), **** requirement *** ** ***** ***** *** 11, ****, ***** *** **** *** government ***** *****-** *********** ************ *** Federal *********, ************* ********* *** ******.

******: **** ******* *** **** ***** to *** *** **********:**** ******** **** ***** ******* ***********

(1)
(1)